aTyr Pharma | LIFE - Selling And Administration Expenses


aTyr Pharma reported $82.26M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
Ardelyx USD 75.92M 7.69M Dec/2025
aTyr Pharma USD 82.26M 77.46M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.21M 120K Dec/2025
CSL USD 1.23B 498M Dec/2025
Curis USD 4.79M 100K Jun/2024
Galapagos EUR 44.42M 9.87M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Grifols EUR 320.45M 12.65M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
United Therapeutics USD 190.6M 38.6M Dec/2025
Xoma USD 11M 2.54M Jun/2024